Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
RVTY compared with DYN: revenue, margins and what each company keeps, and the suppliers and customers both name
RVTY
Revvity, Inc.
Change
Mkt cap
Revenue
Revenue
DYN
Dyne Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
RVTY
Revvity, Inc.
vs
DYN
Dyne Therapeutics, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Earnings history
Desk
News
Calendar
Saved
Search
Earnings history
last 4 reports each · paired by recency
Method
›
RVTY
0 of 4
at or beyond implied
Report
implied
realized
× implied
Q2 FY26
±8.1%
▼
−3.32%
×0.41
Q1 FY26
±8.7%
▲
+6.69%
×0.77
Feb 2 '26
±9.2%
▼
−1.57%
×0.17
Q3 FY25
±12.0%
▼
−1.75%
×0.15
DYN
0 of 4
at or beyond implied
Report
implied
realized
× implied
Q2 FY26
±16.7%
▲
+2.51%
×0.15
May 11 '26
±21.6%
▲
+4.83%
×0.22
= implied
RVTY realized, solid
DYN realized, hatched
One scale, both sides: full bar = 27%
× = |realized| ÷ implied
Source: market data
Q1 FY26
±26.6%
▲
+3.39%
×0.13
Jan 12 '26
±10.7%
▼
−1.74%
×0.16
RVTY
Revvity, Inc.
Change
168.70
▲
+11.28%
Mkt cap
$16.9B
Revenue
$730M
Q2 FY26
Revenue
$2.9B
FY25
DYN
Dyne Therapeutics, Inc.
Change
17.99
▲
+3.97%
Regular session
Nov 3 '26
Mkt cap
$3.2B
Revenue
—
Revenue
—
vs
Compare
Regular session
Nov 3 '26
RVTY
Revvity, Inc.
vs
DYN
Dyne Therapeutics, Inc.
168.70
▲
+11.28%
Price
17.99
▲
+3.97%
$16.9B
Mkt cap
$3.2B
Q2 FY26
$730M
Revenue
—
FY25
$2.9B
Revenue
—
Change
Change
RVTY
168.70
▲
+11.28%
vs
DYN
17.99
▲
+3.97%
Regular session
Nov 3 '26